fluconazole has been researched along with Antibody Deficiency Syndrome in 11 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluconazole, a new triazole derivative, was evaluated in a pilot study of 34 episodes of candidiasis in 24 children." | 7.68 | Fluconazole in the treatment of candidiasis in immunocompromised children. ( Barigione, G; Castagnola, E; Ciravegna, B; Fioredda, F; Terragna, A; Viscoli, C, 1991) |
| "Efficacies of fluconazole (FLCZ) were evaluated in 8 cases of systemic mycosis (1 case each of candidemia, candiduria, 4 cases of pulmonary candidiasis, and 2 cases of suspected fungemia) complicated in immunocompromised children." | 5.07 | [A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children]. ( Hatae, Y; Ishikawa, A; Ishikawa, Y; Matsumoto, S; Sakiyama, Y; Shimizu, T; Takase, A; Takeda, T; Wagatsuma, Y, 1994) |
| "Fluconazole, a new triazole derivative, was evaluated in a pilot study of 34 episodes of candidiasis in 24 children." | 3.68 | Fluconazole in the treatment of candidiasis in immunocompromised children. ( Barigione, G; Castagnola, E; Ciravegna, B; Fioredda, F; Terragna, A; Viscoli, C, 1991) |
| "The patient died from the Cryptococcus infection on day 74 of the antimycotic therapy." | 1.29 | [Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency]. ( Blaschke-Hellmessen, R; Kabus, M; Kaulen, F; Schwarze, R; Wendisch, J, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Temfack, E | 1 |
| Boyer-Chammard, T | 1 |
| Lawrence, D | 1 |
| Delliere, S | 1 |
| Loyse, A | 1 |
| Lanternier, F | 1 |
| Alanio, A | 1 |
| Lortholary, O | 1 |
| Rujirachun, P | 1 |
| Sangwongwanich, J | 1 |
| Chayakulkeeree, M | 1 |
| Frith, J | 1 |
| Toller-Artis, E | 1 |
| Tcheurekdjian, H | 1 |
| Hostoffer, R | 1 |
| Permaul, P | 1 |
| Narla, A | 1 |
| Hornick, JL | 1 |
| Pai, SY | 1 |
| Shah, S | 1 |
| Suresh, PV | 1 |
| Maheshwari, S | 1 |
| Rao, S | 1 |
| Lopatin, AS | 1 |
| Ovchinnikov, AIu | 1 |
| Kolbin, AS | 1 |
| Ivanov, DO | 1 |
| Shabalov, NP | 1 |
| Klimko, NN | 1 |
| Karpov, OI | 1 |
| Ishikawa, Y | 1 |
| Shimizu, T | 1 |
| Sakiyama, Y | 1 |
| Matsumoto, S | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Ishikawa, A | 1 |
| Takase, A | 1 |
| Wagatsuma, Y | 1 |
| Wendisch, J | 1 |
| Blaschke-Hellmessen, R | 1 |
| Kaulen, F | 1 |
| Schwarze, R | 1 |
| Kabus, M | 1 |
| Viscoli, C | 1 |
| Castagnola, E | 1 |
| Fioredda, F | 1 |
| Ciravegna, B | 1 |
| Barigione, G | 1 |
| Terragna, A | 1 |
| Muñoz, P | 1 |
| Moreno, S | 1 |
| Garau, X | 1 |
| López Bernaldo de Quirós, JC | 1 |
| Berenguer, J | 1 |
| More, J | 1 |
| Bouza, E | 1 |
4 reviews available for fluconazole and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Topics: Amphotericin B; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus; Drug Therapy | 2019 |
Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Azithromy | 2009 |
[Oropharyngeal candidiasis in the practical work of the otorhinolaryngologist].
Topics: Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis; Diagnosis, Oral; Drug Res | 2010 |
[Prophylaxis of candidosis in case of secondary immunodeficiency].
Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunologic Deficiency Syndromes; Randomized Co | 2003 |
2 trials available for fluconazole and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
[A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children].
Topics: Candidiasis; Child; Female; Fluconazole; Fungemia; Humans; Immune Tolerance; Immunologic Deficiency | 1994 |
[Multicenter study of fluconazole in the treatment of oropharyngeal candidiasis in immunodepressed patients].
Topics: Adult; Candidiasis, Oral; Female; Fluconazole; HIV Infections; Humans; Immunologic Deficiency Syndro | 1990 |
5 other studies available for fluconazole and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
Topics: Acyclovir; Amphotericin B; Autoantibodies; Coinfection; Cryptococcosis; Fluconazole; Herpesvirus 3, | 2020 |
Good syndrome and polymyositis.
Topics: 14-alpha Demethylase Inhibitors; Agammaglobulinemia; Aged; Fluconazole; Humans; Immunity, Cellular; | 2014 |
Cardiac mucormycosis with T-cell immunodeficiency.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Immunologic Deficiency Syndromes; In | 2009 |
[Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Topics: Adolescent; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neofor | 1996 |
Fluconazole in the treatment of candidiasis in immunocompromised children.
Topics: Adolescent; Candidiasis; Child; Child, Preschool; Fluconazole; Humans; Immunologic Deficiency Syndro | 1991 |